Comerica Bank
JANX icon

Comerica Bank’s Janux Therapeutics JANX Stock Holding History

Comerica Bank’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$386 Sell
28
-76
-73% -$1.79K ﹤0.01% 3652
2025
Q3 		$2.54K Buy
104
+76
+271% +$1.85K ﹤0.01% 3497
2025
Q2 		$647 Sell
28
-151
-84% -$3.98K ﹤0.01% 3602
2025
Q1 		$4.83K Sell
179
-10
-5% -$377 ﹤0.01% 3326
2024
Q4 		$10.1K Buy
189
+128
+210% +$6.77K ﹤0.01% 3170
2024
Q3 		$2.77K Hold
61
– – ﹤0.01% 3444
2024
Q2 		$2.56K Buy
+61
New +$2.86K ﹤0.01% 3442

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Comerica Bank's JANX Position: Q4 2025 in Review

Comerica Bank reduced its Janux Therapeutics (JANX) stake by 73% in Q4 2025, selling an estimated $1.79K and leaving 28 shares worth $386. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Comerica Bank first reported a position in JANX in Q2 2024 and has held it in 7 quarters since. The position peaked at $10.1K in Q4 2024. 176 funds tracked by Wall St. Rank hold JANX as of Q4 2025.

  • Comerica Bank held 28 shares of Janux Therapeutics worth $386 as of Q4 2025.
  • Comerica Bank sold 76 Janux Therapeutics shares in Q4 2025, an estimated $1.79K.
  • Janux Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3652 holding.
  • Comerica Bank first reported a position in Janux Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Comerica Bank's Janux Therapeutics position peaked at $10.1K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Janux Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.